Companies that own ITUS Corp.
The Vanguard Group, Inc.
574,109
3.07%
5,355
0%
06/30/2018
Geode Capital Management LLC
87,602
0.47%
0
0%
06/30/2018
UBS Financial Services, Inc.
45,243
0.24%
40,020
0%
06/30/2018
The Bank of New York Mellon Corp. (Investment Management)
43,556
0.23%
0
0%
06/30/2018
BlackRock Fund Advisors
42,741
0.23%
37,921
0%
06/30/2018
Northern Trust Investments, Inc.
36,548
0.2%
0
0%
06/30/2018
Segall Bryant & Hamill LLC
34,800
0.19%
17,400
0%
06/30/2018
Concorde Asset Management LLC (Michigan)
10,000
0.05%
-1,520
0.04%
06/30/2018
Rothschild Asset Management SCS
4,400
0.02%
0
0%
06/30/2017
Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)
4,080
0.02%
4,000
0%
06/30/2018
| Address |
3150 Almaden Expressway
San Jose California 95118
United States
|
|
Employees
|
- |
| Website |
http://www.ituscorp.com |
| Updated |
09/14/2018 |
| ITUS Corp. engages in the development, acquisition and licensing emerging technology in the field of biotechnology. It focuses on platform called Cchek, a series of inexpensive non-invasive blood tests for the early detection of cancer, which is based on the body's immunological response to the presence of a malignancy. The company was founded on November 5, 1982 and is headquartered San Jose, CA. |
